# H2BC5

## Overview
H2BC5 is a gene that encodes the H2B clustered histone 5 protein, a member of the histone H2B family, which plays a crucial role in the structural organization of chromatin. The protein is integral to the formation of nucleosomes, the fundamental units of chromatin, by interacting with other histones such as H2A, H3, and H4. This interaction is essential for DNA packaging and maintaining chromatin stability (Shetty2023Peripheral). H2BC5 is involved in various biological processes, including gene regulation and immune response modulation, particularly in the context of cancer. It has been implicated in the progression and prognosis of glioma, where its expression is associated with poor outcomes and immune escape mechanisms (Jia2022H2B). Additionally, H2BC5 is hypermethylated in certain cancers, such as malignant pluripotent embryonic carcinoma, and serves as an independent prognostic factor in cervical cancer, underscoring its potential as a therapeutic target (Jia2022H2B).

## Clinical Significance
H2BC5 is implicated in the progression and prognosis of glioma, a type of brain tumor. The gene is more highly expressed in glioma tissues compared to normal tissues, and its expression is associated with poor prognosis in glioma patients (Jia2022H2B). H2BC5 is considered a high-risk factor for glioma and is involved in tumor immune escape mechanisms, which can lead to poor outcomes (Jia2022H2B). The gene's expression correlates with immune infiltration, particularly with immune markers such as IL-10 and CD70, which are associated with tumor progression (Jia2022H2B). 

H2BC5 is also hypermethylated in malignant pluripotent embryonic carcinoma, suggesting a role in other cancer types (Jia2022H2B). It serves as an independent prognostic factor for cervical cancer, indicating its broader significance in cancer prognosis (Jia2022H2B). The gene's involvement in pathways related to immune response suppression and tumor progression highlights its potential as a therapeutic target in glioma treatment (Jia2022H2B).

## Interactions
H2BC5, a member of the H2B histone family, participates in various interactions that influence chromatin structure and gene regulation. It is involved in the formation of nucleosomes by interacting with other histones, such as H2A, H3, and H4, to form the nucleosome core, which is essential for DNA packaging and chromatin stability (Shetty2023Peripheral). 

In the context of placebo effects, H2BC5 interacts with H2BC21 and H2AC16, forming a network that impacts pathways like systemic lupus erythematosus, neutrophil extracellular trap formation, and alcoholism. H2BC5 is predicted to interact with H2BC21 through activation or catalyzation and with H2AC16 via binding of their protein products. These interactions are supported by annotations related to protein heterodimerization activity (Shetty2023Peripheral).

In glioma, H2BC5 is part of a network of H2B genes that are correlated with immune cell biomarkers and immune infiltration, suggesting its role in immune response modulation and tumor progression. Knockdown experiments in glioma cell lines indicate that H2BC5, along with other H2B genes, influences cell cycle progression, contributing to glioma development (Jia2022H2B).


## References


1. (Shetty2023Peripheral) Peripheral blood transcriptomic profiling indicates molecular mechanisms commonly regulated by binge-drinking and placebo-effects. This article has 0 citations.

[2. (Jia2022H2B) Jingnan Jia, Zhaocheng Han, Xueke Wang, Xiancheng Zheng, Shurui Wang, and Yinglin Cui. H2b gene family: a prognostic biomarker and correlates with immune infiltration in glioma. Frontiers in Oncology, October 2022. URL: http://dx.doi.org/10.3389/fonc.2022.966817, doi:10.3389/fonc.2022.966817. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2022.966817)